• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: GUIDANT CRM CLONMEL IRELAND VITALITY 2; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

GUIDANT CRM CLONMEL IRELAND VITALITY 2; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR Back to Search Results
Model Number T177
Device Problems High impedance (1291); Inappropriate/Inadequate Shock/Stimulation (1574); Connection Problem (2900)
Patient Problem Atrial Fibrillation (1729)
Event Date 09/28/2016
Event Type  malfunction  
Manufacturer Narrative
An investigation into this issue is currently ongoing.Once any additional information becomes available, the report will be updated.
 
Event Description
Boston scientific received information that the patient with this implantable cardioverter defibrillator (icd) and right ventricular (rv) lead received several inappropriate shocks during atrial fibrillation (af).A review of the icd memory noted that although the shock impedance measurements for the delivered inappropriate shocks were in normal range, the daily measurements showed the shock impedance measurements above 125 ohms.All other lead measurements were in normal range.A memory download was performed and sent to boston scientific technical services (ts) for review.A ts consultant reviewed the data and discussed that the shock impedance measurements increased to above 125 ohms several weeks after the icd and rv lead were implanted, indicating a potential underinsertion or loose connection issue.Additional troubleshooting was discussed.The serial number for the rv lead was not provided and is currently unknown.The patient was hospitalized as a precaution; no adverse patient effects were reported.
 
Manufacturer Narrative
As no further information concerning this report is expected, our investigation is complete.This investigation will be updated should further information be provided.
 
Event Description
Additional information was received that the physician extended the duration time within the icd and is currently managing the patient's heart rate during atrial fibrillation (af) with medication.No interventions have been performed or are being planned.The icd and rv lead remain implanted and in service.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VITALITY 2
Type of Device
IMPLANTABLE CARDIOVERTER DEFIBRILLATOR
Manufacturer (Section D)
GUIDANT CRM CLONMEL IRELAND
guidant ireland
clonmel, tipperary ireland
Manufacturer (Section G)
GUIDANT CRM CLONMEL IRELAND
guidant ireland
clonmel, tipperary ireland
Manufacturer Contact
sonali vasekar
4100 hamline ave. n
st. paul, MN 
6515824786
MDR Report Key6193232
MDR Text Key62972455
Report Number2124215-2016-16899
Device Sequence Number1
Product Code KRG
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 10/28/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date06/20/2015
Device Model NumberT177
Other Device ID NumberVITALITY 2 VR EL
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? Yes
Initial Date Manufacturer Received 10/08/2016
Initial Date FDA Received12/21/2016
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received01/18/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured06/28/2014
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
0185; T177
-
-